Építés alatt – nem éles oldal
Belépés

What researchers published on Lupus (SLE)

26 682 papers, newest first.

Showing 20 of 551

  • Randomizált vizsgálat[Qihuang Jianpi Zishen Granule ameliorates renal injury in patients with systemic lupus erythematosus by regulating immunometabolic reprogramming of macrophages].Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • Vizsgálati eredményA bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial.Nature medicine
  • Vizsgálati eredményEmpowered Relief vs Cognitive Behavioral Therapy for Patients With Systemic Lupus Erythematosus and Chronic Pain: Study Protocol for a National, Randomized, Noninferiority Trial.JMIR research protocols
  • Randomizált vizsgálatImprovement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial.Annals of the rheumatic diseases
  • Vizsgálati eredményA Convergent Mixed-methods Study of the User Perspectives for an Individualized, Computerized, Collaboratively Produced, Evidence-based Patient Self-administered Systemic Lupus Erythematosus Decision Aid.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
  • Vizsgálati eredménySafety and efficacy of low-dose, cord blood-derived CD19 CAR-NK cells with 4-1BB co-stimulation in refractory systemic lupus erythematosus.Med (New York, N.Y.)
  • Randomizált vizsgálatRandomized controlled single-center clinical trial of high-intensity interval training in patients with systemic lupus erythematosus.Journal of autoimmunity
  • Vizsgálati eredményBelimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trials.RMD open
  • Vizsgálati eredményInfluence of sex and systemic lupus erythematosus disease status on cerebral cortex structure.Lupus science & medicine
  • Vizsgálati eredményPhase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosus.Lupus science & medicine
  • Randomizált vizsgálatEfficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet (London, England)
  • Randomizált vizsgálatOrelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study.Journal of autoimmunity
  • Randomizált vizsgálatAnifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis.Clinical pharmacology and therapeutics
  • Randomizált vizsgálatA post hoc analysis of BLISS-LN found Belimumab plus mycophenolate mofetil improves kidney outcomes versus placebo plus mycophenolate mofetil in active lupus nephritis.Kidney international
  • Vizsgálati eredményComparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial.Lupus science & medicine
  • Randomizált vizsgálatRegulatory B cell expansion and type 1 innate lymphoid cell suppression characterise immune modulation in paediatric lupus nephritis.RMD open
  • Randomizált vizsgálatWhole blood transcriptome profiling in patients treated with deucravacitinib and novel mechanistic insights into TYK2 inhibition in lupus: results from a post hoc analysis of the PAISLEY SLE phase 2 trial.Annals of the rheumatic diseases
  • Randomizált vizsgálatEnpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.Lancet (London, England)
  • Randomizált vizsgálatEfficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial.The Lancet. Rheumatology
  • Randomizált vizsgálatEffect of a mobile application-delivered educational video on interest in and uptake of contraception among patients with systemic lupus erythematosus in Thailand: A randomized controlled trial.Contraception